Supernus Pharmaceuticals Aktie
43,80
EUR
-0,60
EUR
-1,35
%
50,42
USD
-0,94
USD
-1,83
%
Werbung
Supernus Pharmaceuticals Aktie Analyse
| 12.11.18 | Supernus Pharmaceuticals Buy | B. Riley FBR | |
| 18.01.18 | Supernus Pharmaceuticals Buy | B. Riley FBR, Inc. | |
| 28.12.17 | Supernus Pharmaceuticals Buy | B. Riley FBR, Inc. | |
| 08.11.17 | Supernus Pharmaceuticals Buy | Stifel, Nicolaus & Co., Inc. | |
| 19.10.17 | Supernus Pharmaceuticals Buy | FBR & Co. | |
| 19.09.17 | Supernus Pharmaceuticals Hold | Stifel, Nicolaus & Co., Inc. | |
| 05.11.15 | Supernus Pharmaceuticals Outperform | Northland Capital | |
| 28.10.15 | Supernus Pharmaceuticals Outperform | Northland Capital | |
|
Werbung
|
|||
| 18.06.15 | Supernus Pharmaceuticals Buy | Stifel, Nicolaus & Co., Inc. | |
Werbung
Werbung